Published by Coherent Market Insights
Posted on September 22, 2021
4 min readLast updated: February 3, 2026
The Asthma Therapeutics Market is set to grow at a 1.9% CAGR by 2027, driven by rising cases of respiratory diseases and awareness campaigns.
Coherent Market Insights recently published an in depth study of Asthma Therapeutics Market covering interesting aspects of the market with supporting development scenarios starting from 2021-2027. The report delivers the clean elaborated structure of the Market comprising each and each business-related information of the market at a worldwide level. the entire range of data associated with the worldwide Market is obtained through various sources and this obtained bulk of the knowledge is arranged, processed, and represented by a gaggle of specialists through the appliance of various methodological techniques and analytical tools like SWOT analysis to get an entire set of trade-based study regarding the Asthma Therapeutics.
Request PDF With Detailed Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2698
This report assesses the growth rate and the market value on the basis of the key market dynamics, as well as the growth inducing factors. The complete study is based on the up-to-date industry news, growth potentials, and Market trends. It also contains an in-depth analysis of the market and competitive scenario, together with the analysis of the leading competitors.
Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.
The global asthma therapeutics market was valued at US$ 17,582.2 million in 2018, and is expected to witness a CAGR of 1.9% during the forecast period (2018 – 2026). The market is also expected to Surpass US$ 20.4 Billion by 2026.
Rise in number of respiratory disease cases is expected to drive growth of the global asthma therapeutics market.
Increasing prevalence of respiratory diseases is expected to drive global asthma therapeutics market growth. For instance, according to the World Health Organization’s (WHO) report 2016, around 235 million people suffer from asthma worldwide, annually. Asthma is a progressive and chronic life-threatening respiratory disease. Hence, increasing number of respiratory disease cases support the global asthma therapeutics market growth.
Moreover, increasing awareness activities are contributing to the global asthma therapeutics market growth. For instance, in May 2019, Koninklijke Philips N.V., launched campaign to increase awareness of asthma and related respiratory diseases, especially in children. This campaign was titled as ‘Help Your Child Fight against Asthma’.
Competitive Analysis:
The key players are highly focusing on innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in optimal strategies. Few Market Key Players are GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
Order a Copy of This Market Report With Instant USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2698
Some Important TOC:
Market Overview
Global Market Landscape by Player
Players Profiles
Global Production, Revenue (Value), Price Trend by Type
Market Analysis by Application
Global Production, Consumption, Export, Import by Region (2013-2021)
Production, Revenue (Value) by Region (2013-2021)
Manufacturing Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Market Dynamics
Global Market Forecast (2021-2027)
Research Findings and Conclusion
Appendix
The following queries are answered in this comprehensive document:
1. What is the market size of the global and regional levels?
2. Which are the top countries and what is their market size?
3. Which are the growth opportunities in the coming years?
4. Which are the top players and what is their market share?
5. Which are the risk factors affecting market growth?
Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Europe or Asia.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Asthma Therapeutics Market to grow at a CAGR of 1.9% By 2027 | Latest Industry Overview, Technology Advancement Trends, Global Market Scope, Top Company Players Analysis appeared first on Gatorledger.
The article focuses on the growth and trends in the Asthma Therapeutics Market, projected to grow at a 1.9% CAGR by 2027.
Increasing prevalence of respiratory diseases and awareness campaigns are key drivers of market growth.
Key players include GlaxoSmithKline, Philips Healthcare, AstraZeneca, and others.
Explore more articles in the Research Reports category
